alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<PAGE>   1
                                                                    EXHIBIT 15.1


    Deloitte & Touche LLP
    333 Clay Street
    Suite 2300
    Houston, Texas 77002

    August 10, 2000

    Sterling Chemicals Holdings, Inc.
    1200 Smith Street, Suite 1900
    Houston, Texas 77002

    We have made a review, in accordance with standards established by the
    American Institute of Certified Public Accountants, of the unaudited interim
    financial information of Sterling Chemicals Holdings, Inc. and subsidiaries
    for the three-month and nine-month periods ended June 30, 2000 and 1999, as
    indicated in our report dated August 10, 2000; because we did not perform an
    audit, we expressed no opinion on that information.

    We are aware that our report referred to above, which is included in your
    Quarterly Report on Form 10-Q for the quarter ended June 30, 2000, is
    incorporated by reference in Registration Statement No. 333-30917 for
    Sterling Chemicals Holdings, Inc. on Form S-3 and in Registration Statement
    No. 333-52795 for Sterling Chemicals Holdings, Inc. on Form S-8.

    We also are aware that the aforementioned report, pursuant to Rule 436(c)
    under the Securities Act of 1933, is not considered a part of the
    Registration Statements prepared or certified by an accountant or a report
    prepared or certified by an accountant within the meaning of Sections 7 and
    11 of that Act.


    DELOITTE & TOUCHE LLP
Exhibit 32.2

CERTIFICATION PURSUANT
TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TO SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In
connection with the Quarterly Report of Theragenics Corporation®, (the
Company) on Form 10-Q for the period ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, James
A. MacLennan, Treasurer and Chief Financial Officer, certify pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

|(1) |  | The Report fully complies with the requirements of section 13(a) or 15(d) of the
          Securities Exchange Act of 1934; and
|--- |  | -------------------------------------------------------------------------------------------------------------------------------

|(2) |  | The information contained in the Report
          fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- |  | --------------------------------------------------------------------------------------------------------------------------------------------------------------

By:/s/ James A. MacLennanJames A. MacLennanTreasurer and Chief
Financial OfficerMay 7, 2004

A signed original of this written
statement required by Section 906 has been provided to Theragenics Corporation® and
will be retained by Theragenics Corporation® and furnished to the Securities and
Exchange Commission or its staff upon request.
EXHIBIT 32

HEALTHCARE REALTY TRUST INCORPORATED

ANNUAL CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Healthcare Realty Trust Incorporated (the Company) on Form 10-K for
the year ended December 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, David R. Emery, Chairman of the Board and Chief Executive Officer of the Company, and I, Scott W. Holmes,
Executive Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ------------------------------------------------------------------------------------------------------------------------------------------------



/s/ David R. EmeryDavid R. EmeryChairman of the Board and Chief Executive Officer/s/ Scott W. HolmesScott W. HolmesExecutive Vice President and Chief Financial Officer


Date: February 22, 2012
Order entered February 1 5 , 2019

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05 - 18 - 00784 - CR No. 05 - 18 - 0078 5 - CR NICHOLAS LEON ALEXAN DER, Appellant

V. THE STATE OF TEXAS, Appellee On Appeal from the 265th Judicial District Court

Dallas County, Texas Trial Court Cause No s . F14 - 39330 - R & F17 - 10320 - R



### O RDER The reporter’s record was filed November 13, 2018. Missing from the record is State’s Exhibit 5, a DVD of appellant’s interview with police, t hat was offered and admitted at trial. We ORDER court reporter Debi Harris to file a supplemental reporter’s record containing a true and correct playable copy of State’s Exhibit 5 within FOURTEEN DAYS of the date of this order

. /s/ CORY L. CARLYLE JUSTICE
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Morlex, Inc.
financial statements for the three months ended March 31, 1999 and is qualified
in its entirety be reference to such financial statements.
</LEGEND>

<S>                                            <C>
<PERIOD-TYPE>                                  3-MOS
<FISCAL-YEAR-END>                                             DEC-31-1999
<PERIOD-START>                                                JAN-01-1999
<PERIOD-END>                                                  MAR-31-1999
<CASH>                                                               3163
<SECURITIES>                                                            0
<RECEIVABLES>                                                           0
<ALLOWANCES>                                                            0
<INVENTORY>                                                             0
<CURRENT-ASSETS>                                                     3163
<PP&E>                                                                  0
<DEPRECIATION>                                                          0
<TOTAL-ASSETS>                                                       3163
<CURRENT-LIABILITIES>                                                2061
<BONDS>                                                                 0
<COMMON>                                                            31420
<PREFERRED-MANDATORY>                                                   0
<PREFERRED>                                                             0
<OTHER-SE>                                                         (30318)
<TOTAL-LIABILITY-AND-EQUITY>                                         3163
<SALES>                                                                 0
<TOTAL-REVENUES>                                                        0
<CGS>                                                                   0
<TOTAL-COSTS>                                                           0
<OTHER-EXPENSES>                                                     3086
<LOSS-PROVISION>                                                        0
<INTEREST-EXPENSE>                                                      0
<INCOME-PRETAX>                                                     (3086)
<INCOME-TAX>                                                            0
<INCOME-CONTINUING>                                                 (3086)
<DISCONTINUED>                                                          0
<EXTRAORDINARY>                                                         0
<CHANGES>                                                               0
<NET-INCOME>                                                        (3086)
<EPS-BASIC>                                                           0
<EPS-DILUTED>                                                           0


</TABLE>
<PAGE>
                                                                   EXHIBIT 10.82

                                  EXTENSION TO
                               SEVERANCE AGREEMENT

        This Extension to Severance Agreement (the "Amendment") is made
effective as of February 27, 2002 by and between Catalyst Semiconductor, Inc.,
("Corporation") and Frank Reynolds ("Employee") and amends the Severance
Agreement between the Corporation and Employee dated as of May 11, 1999 (the
"Original Agreement"). Terms not otherwise defined in this Amendment shall have
the meaning ascribed to them in the Original Agreement.

                                    RECITALS

        1. Employee is employed by the Corporation.

        2. The Corporation and Employee entered into the Original Agreement with
respect to Employee's employment by the Corporation.

        3. The Company and Employee mutually desire to amend the Original
Agreement to extend the term until April 30, 2003.


                                    AGREEMENT

        In consideration of the mutual convents hereinafter contained, the
Corporation and Employee agree as follows:

        1. Section 1 of the Original Agreement is hereby amended and restated to
read in its entirety as follows:

                INVOLUNTARY TERMINATION. If Employee's employment is terminated
                as a result of Involuntary Termination other than for cause, at
                any time prior to April 30, 2003, Employee will be entitled to
                consideration as defined below.

        2. All other provisions of the Original Agreement shall remain in full
force and effect.

        3. This Amendment may be executed in any number of counterparts, each of
which shall be enforceable against the parties, and all of which together shall
constitute one instrument.

        4. This Amendment shall be governed in all respects by the laws of the
State of California without giving effect to principles of conflicts of law.



<PAGE>

        IN WITNESS WHEREOF, this First Amendment to the Severance Agreement is
hereby executed as of the date first above written.

COMPANY:

CATALYST SEMICONDUCTOR, INC.

By:  /s/ Radu Vanco
----------------------------------
        Radu Vanco
        President & CEO

AGREED TO AND ACCEPTED
THIS 27TH DAY OF FEBRUARY, 2002:

EMPLOYEE:

By:     /s/ Frank Reynolds
----------------------------------
Name:  Frank Reynolds



                                      -2-
CCC OF NEW JERSEY, INC.
                 197 FIRST AVENUE, NEEDHAM, MASSACHUSETTS 02494

                                                                  Exhibit 10.187
                                                            As of March 30, 1999

CareMatrix of Princeton (SNF), Inc.
197 First Avenue
Needham, Massachusetts 02494

      Re:   Lease dated as of August 7, 1998, by and between CCC of New Jersey,
            Inc. ("Chancellor"), as landlord, and CareMatrix of Princeton (SNF),
            Inc. ("CareMatrix"), as tenant (the "Lease")

Ladies and Gentlemen:

      This letter agreement is intended to confirm our understanding with
respect to certain aspects of the above-referenced Lease, and to acknowledge the
payment by you of certain amounts in connection therewith. Capitalized terms
used herein and not defined herein shall have the meanings for such terms set
forth in the Lease.

      CareMatrix and Chancellor hereby confirm and agree that in connection with
our entering into the Lease, CareMatrix agreed to bear all expenses incurred in
connection with the operation of the Leased Property, including, without
limitation, that certain working capital loan from The Chase Manhattan Bank in
the original principal amount of $2,000,000 (the "W/C Loan").

      We hereby acknowledge that we have received from you today the sum of
$2,000,000, which amount has been used by us to payoff and discharge in full all
obligations under the W/C Loan.

      Please indicate your acknowledgement and agreement to the matters set
forth herein by signing the enclosed counterpart of this letter where indicated
and returning it to the undersigned.


                                                Very truly yours,

                                                CCC OF NEW JERSEY, INC.

                                                By:/s/ Abraham D. Gosman
                                                   ------------------------
                                                Name:
                                                Title:
                                                hereunto duly authorized

Acknowledged and agreed as of this 30th day of March, 1999

CAREMATRIX OF PRINCETON (SNF), INC.

By:/s/ David B. Currie
   -------------------
Name: David B. Currie
Title:VP
hereunto duly authorized
# C_2015158EN.01001501.xml

| 13.5.2015 | EN | Official Journal of the European Union | C 158/15 |
| --- | --- | --- | --- |

13.5.2015

EN

Official Journal of the European Union

C 158/15

---

JUDGMENT OF THE COURT

of 10 November 2014

in Case E-8/14

EFTA Surveillance Authority v Iceland

v

(Failure by a Contracting Party to fulfil its obligations — Directive 2009/38/EC — Failure to implement)

(2015/C 158/09)

In Case E-8/14, EFTA Surveillance Authority v Iceland — APPLICATION for a declaration that by failing, within the time prescribed to adopt and/or to notify the EFTA Surveillance Authority forthwith of all measures necessary to implement the Act referred to at point 27 of Annex XVIII to the Agreement on the European Economic Area, that is Directive 2009/38/EC of the European Parliament and of the Council of 6 May 2009 on the establishment of a European Works Council or a procedure in Community-scale undertakings and Community-scale groups of undertakings for the purposes of informing and consulting employees (Recast), as adapted to the Agreement by way of Protocol 1 thereto and by EEA Joint Committee Decision No 54/2010 of 30 April 2010, Iceland has failed to fulfil its obligations under the Act and Article 7 EEA, the Court, composed of Carl Baudenbacher, President, Per Christiansen (Judge-Rapporteur) and Páll Hreinsson, Judges, gave judgment on 10 November 2014, the operative part of which is as follows:

The Court hereby:

| 1. | Declares that by failing, within the time prescribed, to adopt all the measures necessary to implement the Act referred to at point 27 of Annex XVIII to the Agreement on the European Economic Area, that is Directive 2009/38/EC of the European Parliament and of the Council of 6 May 2009 on the establishment of a European Works Council or a procedure in Community-scale undertakings and Community-scale groups of undertakings for the purposes of informing and consulting employees (Recast), as adapted to the EEA Agreement by way of Protocol 1 thereto and by Joint Committee Decision No 54/2010, Iceland has failed to fulfil its obligations under the Act and under Article 7 of the Agreement. |
| --- | --- |

1.

Declares that by failing, within the time prescribed, to adopt all the measures necessary to implement the Act referred to at point 27 of Annex XVIII to the Agreement on the European Economic Area, that is Directive 2009/38/EC of the European Parliament and of the Council of 6 May 2009 on the establishment of a European Works Council or a procedure in Community-scale undertakings and Community-scale groups of undertakings for the purposes of informing and consulting employees (Recast), as adapted to the EEA Agreement by way of Protocol 1 thereto and by Joint Committee Decision No 54/2010, Iceland has failed to fulfil its obligations under the Act and under Article 7 of the Agreement.

| 2. | Orders Iceland to bear the costs of the proceedings. |
| --- | --- |

2.

Orders Iceland to bear the costs of the proceedings.

---
Order entered September 4, 2018

In The 

## Court of Appeals **Fifth District of Texas at Dallas**

No. 05-18-00993-CV No. 05-18-00994-CV

IN RE SHEMONT JAYRON GULLATT, Relator

Original Proceeding from the 363rd Judicial District Court Dallas County, Texas Trial Court Cause Nos. F-11-61616-W and F-11-70820-W



### ORDER Before Justices Bridges, Brown, and Boatright

Based on the Court’s opinion of this date, we DENY relator’s petition for writ of

mandamus.

/s/ DAVID L. BRIDGES JUSTICE
May 21, 1997 

       Securities and Exchange Commission 
       450 Fifth Street, N.W. 
       Washington, D.C. 20549 

            Re:  Vitro Diagnostics, Inc. 
                    Form 10-QSB for the year ending April 30, 1997
                    SEC file no.  0-17378 

       Dear Sir or Madam:

       Transmitted herewith through the EDGAR system is Form 10-QSB for the 
quarter ended April 30, 1997 for Vitro Diagnostics, Inc.  Should you have 
any questions or comments concerning this matter please contact the 
undersigned at 303-794-2000.



       Sincerely, 



       Roger Hurst 
       President 


<PAGE>
From: McKaughan, Colleen

Sent: Tuesday, February 26, 2013 5:30:31 PM

To: vmartz@srmaterials.com; Gary.Bohnee@SRPMIC-nsn.gov

Cc: Nudd, Gregory; Webb, Thomas; Kelly, Shaheerah; ecm@azdeq.gov

Subject: New Court-Ordered Deadline for Regional Haze FIP

Dear Verle and Gary,

I’m writing to let you know that the court-ordered deadline for EPA to propose a Federal 

Implementation Plan (FIP) addressing regional haze in Arizona has been extended to September 

6, 2013. Our deadline for final action on Arizona’s State Implementation Plan (SIP) remains July 

15, 2013. The deadline for commenting on our December 20, 2012 proposed action on 

Arizona’s SIP is March 6, 2013. 

If EPA finalizes disapproval of any aspect of the Arizona Regional Haze SIP, we are obligated to 

propose and later finalize a FIP to address these disapproved portions. The deadlines for these 

proposed and final actions are set in a consent decree. The parties to the consent decree 

recently agreed to extend these deadlines and the United States District Court for the District of 

Columbia issued an order granting a motion to amend the consent decree to reflect these new 

deadlines. The new deadlines of September 6, 2013 for the proposed action and February 6, 

2014 for the final action provide the agency more time for the technical work that will form the 

basis of the FIP. 

If you are planning to provide technical information that you think would be helpful to EPA in 

preparing our FIP proposal, please provide that information no later than May 10, 2013. This 

will allow us enough time to review and consider the information in preparing the proposal.

In the case of Kiln 4 at the Phoenix Cement Company in Clarksdale, Arizona, we are particularly 

interested in getting your feedback regarding the effectiveness of potential controls and the 

control costs estimated by our contractor, as well as information about whether the kiln 

employs existing inherent or add-on controls for minimizing nitrogen oxide emissions. 

If you have any questions, please let me know. We look forward to hearing from you soon. I 

have contacted Gary in order to arrange the meetings and consultation that the Salt River PimaMaricopa Indian Community has requested. We are awaiting potential dates.

Colleen McKaughan

520-498-0118
# C_2021472EN.01000601.xml

| 23.11.2021 | EN | Official Journal of the European Union | C 472/6 |
| --- | --- | --- | --- |

23.11.2021

EN

Official Journal of the European Union

C 472/6

---

Euro exchange rates (1)

22 November 2021

(2021/C 472/06)

1 euro =

| | Currency | Exchange rate |
| --- | --- | --- |
| USD | US dollar | 1,1278 |
| JPY | Japanese yen | 128,69 |
| DKK | Danish krone | 7,4368 |
| GBP | Pound sterling | 0,83923 |
| SEK | Swedish krona | 10,1280 |
| CHF | Swiss franc | 1,0454 |
| ISK | Iceland króna | 148,20 |
| NOK | Norwegian krone | 10,0715 |
| BGN | Bulgarian lev | 1,9558 |
| CZK | Czech koruna | 25,373 |
| HUF | Hungarian forint | 369,12 |
| PLN | Polish zloty | 4,6984 |
| RON | Romanian leu | 4,9496 |
| TRY | Turkish lira | 12,6714 |
| AUD | Australian dollar | 1,5532 |
| CAD | Canadian dollar | 1,4257 |
| HKD | Hong Kong dollar | 8,7875 |
| NZD | New Zealand dollar | 1,6095 |
| SGD | Singapore dollar | 1,5357 |
| KRW | South Korean won | 1 338,72 |
| ZAR | South African rand | 17,7799 |
| CNY | Chinese yuan renminbi | 7,1975 |
| HRK | Croatian kuna | 7,5185 |
| IDR | Indonesian rupiah | 16 075,81 |
| MYR | Malaysian ringgit | 4,7204 |
| PHP | Philippine peso | 57,146 |
| RUB | Russian rouble | 84,4872 |
| THB | Thai baht | 37,116 |
| BRL | Brazilian real | 6,3043 |
| MXN | Mexican peso | 23,5855 |
| INR | Indian rupee | 83,8520 |

Currency

Exchange rate

USD

US dollar

1,1278

JPY

Japanese yen

128,69

DKK

Danish krone

7,4368

GBP

Pound sterling

0,83923

SEK

Swedish krona

10,1280

CHF

Swiss franc

1,0454

ISK

Iceland króna

148,20

NOK

Norwegian krone

10,0715

BGN

Bulgarian lev

1,9558

CZK

Czech koruna

25,373

HUF

Hungarian forint

369,12

PLN

Polish zloty

4,6984

RON

Romanian leu

4,9496

TRY

Turkish lira

12,6714

AUD

Australian dollar

1,5532

CAD

Canadian dollar

1,4257

HKD

Hong Kong dollar

8,7875

NZD

New Zealand dollar

1,6095

SGD

Singapore dollar

1,5357

KRW

South Korean won

1 338,72

ZAR

South African rand

17,7799

CNY

Chinese yuan renminbi

7,1975

HRK

Croatian kuna

7,5185

IDR

Indonesian rupiah

16 075,81

MYR

Malaysian ringgit

4,7204

PHP

Philippine peso

57,146

RUB

Russian rouble

84,4872

THB

Thai baht

37,116

BRL

Brazilian real

6,3043

MXN

Mexican peso

23,5855

INR

Indian rupee

83,8520

---

(1)  Source: reference exchange rate published by the ECB.

---
# C_2022433EN.01005501.xml

| 15.11.2022 | EN | Official Journal of the European Union | C 433/55 |
| --- | --- | --- | --- |

15.11.2022

EN

Official Journal of the European Union

C 433/55

---

NOTICE PURSUANT TO ARTICLE 29(2) OF THE STAFF REGULATIONS

Publication of a vacancy for three functions of Director ‘Resources’ (Grade AD 14) in the Directorates-General for:

International Partnerships (INTPA)

Health and Food Safety (SANTE)

Trade (TRADE)

COM/2022/10419

(2022/C 433/20)

The European Commission has published a vacancy notice (reference COM/2022/10419) for three functions of Director ‘Resources’ (Grade AD 14) in the Directorates-General for International Partnership (INTPA), Health and Food Safety (SANTE) and Trade (TRADE).

To consult the text of the vacancy notice in 24 languages and to submit your application, please visit this dedicated webpage on the European Commission’s website: https://europa.eu/!RNhCDw

---